Genocea Biosciences (GNCA) 5.36 $GNCA Research Report

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Genocea Biosciences (GNCA) 5.36 $GNCA

Research Report Initiation on Biotech Stocks -- Agenus, ProNAi Therapeutics, Vanda Pharma, and Genocea Biosciences
PR Newswire - Thu Aug 11, 7:40AM CDT
This morning on Stock-Callers.com we have Biotech industry under review. This segment is focused on new drug developments and clinical researches. Stocks under evaluation are: Agenus Inc. (NASDAQ: AGEN), ProNAi Therapeutics Inc. (NASDAQ: DNAI), Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), and Genocea Biosciences Inc. (NASDAQ: GNCA). Learn more about these stocks by downloading their free report at:
AGEN: 6.19 (-0.23), VNDA: 15.38 (-0.34), GNCA: 5.36 (-0.03), DNAI: 1.83 (-0.03)

Genocea Congratulates Jessica Baker Flechtner, Ph.D. for Recognition on 2016's 40 Women To Watch Over 40 List
GlobeNewswire - Tue Aug 09, 6:30AM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, is delighted to congratulate Jessica Baker Flechtner, Ph.D., chief scientific officer, who was acknowledged as an honoree on this year's 40 Women to Watch Over 40 list. The list, founded in 2013, celebrates the achievements of women over 40 who are pushing boundaries in their respective industries.
GNCA: 5.36 (-0.03)

Genocea Reports Second Quarter 2016 Financial Results
GlobeNewswire - Thu Aug 04, 6:30AM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today reported corporate highlights and financial results for the second quarter ended June 30, 2016.
GNCA: 5.36 (-0.03)

Genocea to Host Second Quarter 2016 Financial Results Conference Call & Webcast on August 4, 2016
GlobeNewswire - Thu Jul 28, 7:00AM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that it will host a conference call and live audio webcast on Thursday, August 4, 2016 at 9:00 a.m. ET to discuss financial results for the second quarter of 2016. Genocea management will provide an update on the Company's recent progress and upcoming milestones.
GNCA: 5.36 (-0.03)

Genocea Appoints Ron Cooper to Board of Directors
GlobeNewswire - Thu Jun 09, 3:30PM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Ron Cooper has joined its board of directors, effective immediately. Mr. Cooper currently serves as president and chief executive officer at Albireo Ltd.
GNCA: 5.36 (-0.03), BMY: 57.39 (+0.15)

Genocea Showcases Potential of Genital Herpes Immunotherapy GEN-003 at ASM Microbe 2016
GlobeNewswire - Thu Jun 09, 6:30AM CDT
- Presentation of GEN-003 12-Month Data Featured in ASM Press Briefing -
GNCA: 5.36 (-0.03)

What Investors Think of These Biotech Stocks? - Genocea Biosciences, BioDelivery Sciences Intl., INSYS Therapeutics, and Agios Pharma
PR Newswire - Thu Jun 02, 7:20AM CDT
Restructuring activities within the Biotech industry as well as the nearing U.S. presidential election continues to affect the overall condition of firms in this space. But despite the uncertainties, investors see potential growth in select companies that. Today, ActiveWallSt.com reviews the performances of the following equities: Genocea Biosciences Inc. (NASDAQ: GNCA), BioDelivery Sciences International Inc. (NASDAQ: BDSI), INSYS Therapeutics Inc. (NASDAQ: INSY), and Agios Pharmaceuticals Inc. (NASDAQ: AGIO). Click below to get your complimentary trade alerts:
BDSI: 2.44 (+0.01), INSY: 14.27 (-0.06), AGIO: 36.84 (+0.22), GNCA: 5.36 (-0.03)

Genocea Appoints Dr. John E. Bishop as Senior Vice President of Pharmaceutical Sciences
GlobeNewswire - Mon May 23, 6:30AM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that John E. Bishop, Ph.D. has joined the company as senior vice president of pharmaceutical sciences.
GNCA: 5.36 (-0.03)

Genocea Biosciences Implements Wingspan eTMF
BusinessWire - Wed May 18, 11:38AM CDT
Genocea Biosciences has partnered with Wingspan Technology to implement a validated, inspection-ready, 21-CFR-Part 11 compliant electronic system. The implementation provides one central location for internal employees, contracted partners, and potential regulatory inspectors to quickly access Genocea's clinical documentation in a controlled environment.
GNCA: 5.36 (-0.03)

Genocea to Present at the 2016 UBS Global Healthcare Conference
GlobeNewswire - Tue May 17, 7:00AM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that management will present a company overview at the upcoming 2016 UBS Global Healthcare Conference on Tuesday, May 24, 2016 at 9:00 a.m. ET in New York, NY.
GNCA: 5.36 (-0.03)

Genocea Biosciences reports 1Q loss
Automated Insights - Thu May 05, 8:29AM CDT
CAMBRIDGE, Mass. (AP) _ Genocea Biosciences Inc. (GNCA) on Thursday reported a loss of $9.8 million in its first quarter.
GNCA: 5.36 (-0.03)

Genocea Reports First Quarter 2016 Financial Results
GlobeNewswire - Thu May 05, 7:05AM CDT
- Positive 12-month efficacy data for GEN-003 for genital herpes strengthens value proposition -
GNCA: 5.36 (-0.03)

Regeneron (REGN) Q1 Earnings: Stock Likely to Disappoint
Zacks Equity Research - Zacks Investment Research - Mon May 02, 10:54AM CDT
Regeneron Pharmaceuticals (REGN), which is set to report first-quarter 2016 results on May 5, recorded a negative earnings surprise of 45.93% last quarter.
GNCA: 5.36 (-0.03), SNY: 38.47 (-0.31), REGN: 392.55 (-2.67)

Celldex (CLDX): What's Ahead for the Stock in Q1 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 10:52AM CDT
Celldex (CLDX) is expected to report first-quarter 2016 results on May 4.
ZTS: 51.10 (+0.35), CLDX: 3.32 (-0.11), GNCA: 5.36 (-0.03), BMY: 57.39 (+0.15)

Endo (ENDP) Q1 Earnings: What's in Store for the Stock?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:58AM CDT
Endo International (ENDP), which is set to report first-quarter 2016 results on May 5, delivered a positive earnings surprise of 7.09% last quarter.
IPXL: 24.19 (-0.23), ENDP: 20.70 (-0.19), JAZZ: 123.83 (-2.40), GNCA: 5.36 (-0.03)

Zoetis (ZTS): Stock Likely to Beat on Earnings in Q1 Again?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:56AM CDT
Zoetis (ZTS), which is set to report first-quarter 2016 results on May 4, delivered a positive earnings surprise of 10.26% last quarter.
ZTS: 51.10 (+0.35), ABT: 42.02 (-0.81), JAZZ: 123.83 (-2.40), GNCA: 5.36 (-0.03)

Genocea to Host First Quarter 2016 Financial Results Conference Call & Webcast on May 5, 2016
GlobeNewswire - Thu Apr 28, 7:02AM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that it will host a conference call and live audio webcast on Thursday, May 5, 2016 at 9:00 a.m. ET to discuss financial results for the first quarter of 2016. Genocea management will provide an update on the Company's recent progress and upcoming milestones.
GNCA: 5.36 (-0.03)

Mylan (MYL) Q1 Earnings: What's in the Cards for the Stock?
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 6:20AM CDT
Mylan (MYL), which is set to report first-quarter 2016 results on May 3, delivered a negative earnings surprise of 2.40% in the last quarter.
MYL: 42.36 (-0.39), AGIO: 36.84 (+0.22), GNCA: 5.36 (-0.03), SNY: 38.47 (-0.31)

Genocea Congratulates Dr. George Siber, 2016 Albert B. Sabin Gold Medal Award Recipient
GlobeNewswire - Wed Apr 20, 7:00AM CDT
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, is delighted to congratulate Dr. George R. Siber, board member and chair of Genocea's scientific advisory boards, on being awarded the 2016 Albert B. Sabin Gold Medal Award by the Sabin Vaccine Institute. The award recognizes his research contributions in the development of innovative vaccines, including the first pneumococcal conjugate vaccine, the first meningococcal conjugate vaccine and the first antibody for the prevention of RSV infections. He was also involved in development of the first rotavirus vaccine and live attenuated influenza vaccine. This prestigious honor -- the highest scientific honor granted by the Sabin Vaccine Institute and one of the most important in the field of vaccinology -- is awarded annually to a distinguished member of the public health community who has pioneered work in vaccinology or a complementary field.
GNCA: 5.36 (-0.03)

3 Scorching Hot Healthcare Stocks -- Are They Buys?
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 13, 7:03AM CDT
SOURCE: FLICKR USER PICTURES OF MONEY. Worries over payer pushback on sky-high prices have taken a toll on many healthcare stocks, but some stocks are bucking the trend and rewarding investors with eye-popping returns. Among the best performing of...
ISRG: 686.42 (-1.11), CPXX: 30.24 (unch), GNCA: 5.36 (-0.03), TRXC: 1.37 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dar Global Expands Jeddah Portfolio with $267M Project

Updated Category News Views 77

Dar Global's Big Jeddah Move: A $267M Bet Alright, let's dive into what Dar Global's been up to in Saudi Arabia. They've just announced a whopping SAR 1 billion development project in Jeddah, bringing an international luxury brand to the city with an exclusive co-branded residential concept. Now that's something to chew on for any investor eyeing the Middle East's real...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 55

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 46

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 0

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 70

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
HONOR Leads in China, Eyes Middle East Market

Updated Category News Views 78

A Force to be Reckoned With Talk about making waves—HONOR's got the bragging rights now. Sitting pretty at the top among Android smartphone brands in China ain't no small feat. We're looking at a snazzy 12.04% market share for October 2026, all thanks to selling a cool 2.573 million units. The kicker? This ain't even their full potential. They're hustling hard in the...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 74

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Gayatri Pariwar Celebrates 100 Years with Massive Yoga Event

Updated Category News Views 52

An Impressive Centenary for Gayatri Pariwar Sometimes, you get hit by a wave so big you can't ignore it, and Gayatri Pariwar's centennial festival in New Delhi was one such tsunami. Picture this: countless souls gathered to mark a hundred years of spiritual and social reform, not just with chants and talks, but through an awe-inspiring mass yoga event. In my decades...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 12

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 23

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading

Top 5 Most Recently Viewed Articles

White Castle Introduces Unbeatable $4 Deal for Sliders

Updated Category News Views 212

White Castle Launches Exclusive $4 Slider Offer Beginning May 9, White Castle is rolling out an enticing promotion: six Original Sliders for just $4. This limited-time offer brings the price of the sliders below what customers paid back in 2012, making it a fantastic opportunity for those seeking budget-friendly meal options. The price breakdown amounts to less than 67...

Continue Reading
Alienware Revives Iconic Area-51 Gaming System for Fans

Updated Category News Views 423

Alienware Reintroduces Area-51 Systems Alienware, a brand known for pushing the boundaries of gaming hardware, is thrilled to announce the comeback of the legendary Area-51. This fan-favorite line has been revitalized, now available in both desktop and laptop versions, ensuring that gamers can enjoy cutting-edge performance in their preferred format. Rich History of...

Continue Reading
LifeStance Health Group's Impressive Q2 2025 Performance Highlights

Updated Category News Views 227

LifeStance Reports Strong Financial Performance in Q2 2025 LifeStance Health Group, Inc. (NASDAQ: LFST), a leading provider of outpatient mental healthcare across the United States, has showcased its robust growth with the release of its financial results for the second quarter of 2025. This period witnessed LifeStance achieving remarkable revenue growth alongside...

Continue Reading
First Financial Corporation Announces New Dividend Update

Updated Category News Views 127

First Financial Corporation's Latest Dividend Declaration The directors of First Financial Corporation (NASDAQ: THFF) have made an exciting announcement regarding their quarterly dividend. The company declared a dividend of 51 cents per share. This payment will provide a valuable return for shareholders and is scheduled to be paid out shortly. A record of shareholders...

Continue Reading
Desjardins Expands Commitment to Affordable Housing Units by 2028

Updated Category News Views 267

Desjardins Group's Pledge for Affordable Housing In response to the urgent housing crisis, Desjardins Group is taking bold steps to address the pressing need for affordable housing. They recently announced an ambitious plan to construct over 10,000 affordable and deferred-affordability housing units aimed at assisting families, students, and individuals who are struggling...

Continue Reading